AVCO Key Statistics, Chart & Performance
The current stock price of AVCO is 0.5259 USD. In the past month the price increased by 4.7%. In the past year, price decreased by -49.43%.
AVCO Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AVCO. When comparing the yearly performance of all stocks, AVCO is a bad performer in the overall market: 80.4% of all stocks are doing better.
AVCO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AVCO. AVCO has a bad profitability rating. Also its financial health evaluation is rather negative.
AVCO Financial Highlights
Over the last trailing twelve months AVCO reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 27.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -600.07% | ||
| ROA | -82.31% | ||
| ROE | N/A | ||
| Debt/Equity | 14 |
AVCO Forecast & Estimates
AVCO Ownership
AVCO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LB | LANDBRIDGE CO LLC-A | 28.39 | 4.172B | ||
| KW | KENNEDY-WILSON HOLDINGS INC | N/A | 1.35B | ||
| TCI | TRANSCONTINENTAL REALTY INV | N/A | 481.248M | ||
| FRPH | FRP HOLDINGS INC | N/A | 449.129M | ||
| MLP | MAUI LAND & PINEAPPLE CO | N/A | 336.764M | ||
| ARL | AMERICAN REALTY INVESTORS IN | N/A | 288.923M | ||
| SEG | SEAPORT ENTERTAINMENT GROUP | N/A | 246.774M | ||
| OZ | BELPOINTE PREP LLC- CLASS A | N/A | 205.198M | ||
| SRG | SERITAGE GROWTH PROP- A | N/A | 179.098M | ||
| LPA | LOGISTIC PROPERTIES OF THE A | N/A | 90.462M |
Related stock screener links
View all stocks in the Real Estate Operating Companies Industry | View all stocks in the Real Estate Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVCO
Company Profile
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
Company Info
AVALON GLOBOCARE CORP
4400 ROUTE 9, SUITE 3100
Freehold NEW JERSEY 07728 US
CEO: David Jin
Employees: 5
Phone: 17327804400.0
AVALON GLOBOCARE CORP / AVCO FAQ
What does AVALON GLOBOCARE CORP do?
Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.
Can you provide the latest stock price for AVALON GLOBOCARE CORP?
The current stock price of AVCO is 0.5259 USD. The price decreased by -16.52% in the last trading session.
What is the dividend status of AVALON GLOBOCARE CORP?
AVCO does not pay a dividend.
What is the ChartMill rating of AVALON GLOBOCARE CORP stock?
AVCO has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for AVALON GLOBOCARE CORP?
AVALON GLOBOCARE CORP (AVCO) operates in the Real Estate sector and the Real Estate Management & Development industry.
What is the market capitalization of AVCO stock?
AVALON GLOBOCARE CORP (AVCO) has a market capitalization of 46.82M USD. This makes AVCO a Nano Cap stock.
Can you provide the ownership details for AVCO stock?
You can find the ownership structure of AVALON GLOBOCARE CORP (AVCO) on the Ownership tab.